Clinical assessment in juvenile dermatomyositis

References

• Compeyrot-Lacassagne S, Feldman BM. Inflammatory myopathies in children. Pediatr Clin North Am 2005; 52: 493–520
   PubMedGoogle Scholar
• Wedderburn LR, Li CK. Paediatric idiopathic inflammatory muscle disease. Best Pract Res Clin Rheumatol 2004; 18: 345–358
   PubMedGoogle Scholar
• Cassidy JT, Petty RE. Juvenile dermatomyositis. Textbook of pediatric rheumatology4th ed., JT Cassidy, RE Petty. WB Saunders, Philadelphis 2001; 465–504
   Google Scholar
• Kim B, Kaistha SD, Rouse BT. Viruses and autoimmunity. Autoimmunity 2005; 38: 559–565
   PubMed Web of Science ®Google Scholar
• Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 2005; 38: 235–245
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity 2005; 38: 473–485
   PubMed Web of Science ®Google Scholar
• Kendall FP, McCreary EK, Provance PG. Muscles: Testing and function4th ed. Williams and Wilkins, Baltimore 1993
   Google Scholar
• Hicks J, Wesley R, Koziol D, et al. Validation of manual muscle testing in the assessment of juvenile dermatomyositis. Arthritis Rheum 2000; 43(Suppl.)S194
   Google Scholar
• Escolar DM, Henricson EK, Mayhew J, et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 2001; 24: 787–793
   PubMed Web of Science ®Google Scholar
• Hicks J, Wesley R, Koziol D, et al. Consensus and economic advantages in use of abbreviated manual muscle testing in the assessment of idiopathic inflammatory myopathies (abstract). Arthritis Rheum 2001; 44(Suppl.)S352
   Google Scholar
• Hicks J, Wesley R, Koziol D, et al. Preliminary validation of abbreviated manual muscle testing in the assessment of juvenile dermatomyositis. Arthritis Rheum 2000; 43(Suppl.)S195
   PubMedGoogle Scholar
• Rider LG. Idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002; 28: 1–41
   PubMedGoogle Scholar
• Ramanan AV, Feldman BM. The role of muscle enzymes in JDM. Pediatr Rheumatol Online J 2005; 3: 1–4
   Google Scholar
• Villalba L, Hicks JE, Adams EM, et al. Treatment of refractory myositis: A randomized crossover study of two new cytotoxic regimens. Arthritis Rheum 1998; 41: 392–399
   PubMed Web of Science ®Google Scholar
• Oddis CV, Medsger TA, Jr. Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis–dermatomyositis. J Rheumatol 1988; 15: 807–811
   PubMed Web of Science ®Google Scholar
• Guzman J, Petty RE, Malleson PN. Monitoring disease activity in juvenile dermatomyositis: The role of von Willebrand factor and muscle enzymes. J Rheumatol 1994; 21: 739–743
   PubMed Web of Science ®Google Scholar
• Montecucco C, Ravelli A, Caporali R, Viola S, De Gennaro F, Albani S, Martini A. Autoantibodies in juvenile dermatomyositis. Clin Exp Rheumatol 1990; 8: 193–196
   PubMed Web of Science ®Google Scholar
• Muro Y. Antinuclear antibodies. Autoimmunity 2005; 38: 3–9
   PubMed Web of Science ®Google Scholar
• Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-Jo1 antibodies. Autoimmunity 2005; 38: 73–78
   PubMed Web of Science ®Google Scholar
• Migliorini P, Baldini C, Rocchi V, Bombardieri S. Anti-Sm and anti-RNP antibodies. Autoimmunity 2005; 38: 47–54
   PubMed Web of Science ®Google Scholar
• Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-Mi2 antibodies. Autoimmunity 2005; 38: 79–83
   PubMed Web of Science ®Google Scholar
• Lovell DJ, Lindsley CB, Rennebohm RM, et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): A quantitative tool for the evaluation of muscle function. Arthritis Rheum 1999; 42: 2213–2219
   PubMedGoogle Scholar
• Huber AM, Feldman BM, Rennebohm RM, et al. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004; 50: 1595–1603
   PubMed Web of Science ®Google Scholar
• Rennebohm RM, Jones K, Huber AM, et al. Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale. Arthritis Rheum 2004; 51: 365–370
   PubMed Web of Science ®Google Scholar
• Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994; 37: 1761–1769
   PubMed Web of Science ®Google Scholar
• Feldman BM, Ayling-Campos A, Luy L, et al. Measuring disability in juvenile dermatomyositis: Validity of the childhood health assessment questionnaire. J Rheumatol 1995; 22: 326–331
   PubMedGoogle Scholar
• Huber AM, Hicks JE, Lachenbruch PA, et al. Validation of the childhood health assessment questionnaire in the juvenile idiopathic myopathies. J Rheumatol 2001; 28: 1106–1111, Juvenile Dermatomyositis Disease Activity Collaborative Study Group
   PubMed Web of Science ®Google Scholar
• Ruperto N, Ravelli A, Pistorio A, et al. Cross-cultural adaptation and psychometric evaluation of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol 2001; 19(4 Suppl. 23)S1–S9
   PubMed Web of Science ®Google Scholar
• Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM. Disease activity score for children with juvenile dermatomyositis: Reliability and validity evidence. Arthritis Rheum 2003; 49(1)7–15, Feb 15
   PubMedGoogle Scholar
• Isenberg DA, Allen E, Farewell V, et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology 2004; 43: 49–54
   PubMed Web of Science ®Google Scholar
• Pilkington C. Clinical assessment in juvenile idiopathic inflammatory myopathies and the development of disease activity and damage tools. Curr Opin Rheumatol 2004; 16: 673–677
   PubMedGoogle Scholar
• Rider LG, Feldman BM, Perez MD, et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Arthritis Rheum 1997; 40: 1976–1983, Juvenile Dermatomyositis Disease Activity Collaborative Study Group
   PubMedGoogle Scholar
• Park JH, Olsen NJ. Utility of magnetic resonance imaging in the evaluation of patients with inflammatory myopathies. Curr Rheumatol Rep 2001; 3: 334–345
   PubMedGoogle Scholar
• Eisenstein DM, O'Gorman MRG, Pachman LM. Correlations between change in disease activity and changes in peripheral blood lymphocyte subsets in patients with juvenile dermatomyositis. J Rheumatol 1997; 24: 1830–1832
   PubMed Web of Science ®Google Scholar
• Adams EM, Chow CK, Premkumar A, et al. The idiopathic inflammatory myopathies: Spectrum of MR imaging findings. Radiographics 1995; 15: 563–574
   PubMed Web of Science ®Google Scholar
• Fraser DD, Frank JA, Dalakas M, et al. Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 1991; 18: 1693–1700
   PubMed Web of Science ®Google Scholar
• Kimball AB, Summers RM, Turner M, et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy. Arthritis Rheum 2000; 43: 1866–1873
   PubMedGoogle Scholar
• Hernandez RJ, Keim DR, Sullivan DB, et al. Magnetic resonance imaging appearance of the muscles in childhood dermatomyositis. J Pediatr 1990; 117: 546–550
   PubMedGoogle Scholar
• Schweitzer ME, Fort J. Cost-effectiveness of MR imaging in evaluating polymyositis. AJR Am J Roentgenol 1995; 165: 1469–1471
   PubMedGoogle Scholar
• Maillard SM, Jones R, Owens C, et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology 2004; 43: 603–608
   PubMed Web of Science ®Google Scholar
• Reimers CD, Fleckenstein JL, Witt TN, et al. Muscular ultrasound in idiopathic inflammatory myopathies of adults. J Neurol Sci 1993; 116: 82–92
   PubMed Web of Science ®Google Scholar
• Heckmatt JZ, Dubowitz V. Real-time ultrasound imaging of muscles. Muscle Nerve 1988; 11: 56–65
   PubMed Web of Science ®Google Scholar
• Stonecipher MR, Jorizzo JL, Monu J, et al. Dermatomyositis with normal muscle enzyme concentrations. A single-blind study of the diagnostic value of magnetic resonance imaging and ultrasound. Arch Dermatol 1994; 130: 1294–1299
   PubMedGoogle Scholar
• Pilkington C, Owen NJ, Bose S, et al. A preliminary comparative study of high frequency muscle ultrasound and magnetic resonance imaging in 7 patients with juvenile dermatomyositis. Ann Rheum Dis 2000; 59: 727–728
   PubMedGoogle Scholar
• Meng C, Adler R, Peterson M, et al. Combined use of power Doppler and gray-scale sonography: A new technique for the assessment of inflammatory myopathy. J Rheumatol 2001; 28: 1271–1282
   PubMed Web of Science ®Google Scholar
• Feldman BM, Rider LG, Dugan E, et al. Nailfold capillaries as indicators of disease activity in juvenile idiopathic inflammatory myopathies. Arthritis Rheum 1999; 42(Suppl.)S664
   Google Scholar
• Pachman LM, Mendez E, Kanuru R, et al. Nailfold capillary studies in 50 untreated children with juvenile dermatomyositis. Arthritis Rheum 1998; 41(Suppl.)S265
   Google Scholar
• Scheja A, Elborgh R, Wildt M. Decreased capillary density in juvenile dermatomyositis and in mixed connective tissue disease. J Rheumatol 1999; 26: 1377–1381
   PubMedGoogle Scholar
• Szmidt-Salkowska E, Rowinska-Marcinska K, Lovelace RE. EMG dynamics in polymyositis and dermatomyositis in adults. Electromyogr Clin Neurophysiol 1989; 29(7–8)399–404, Nov–Dec
   PubMedGoogle Scholar
• Sandstedt ER, Enriksson KG, Larsson LE. Quantitative electromyography in polymyositis and dermatomyositis. Acta Neurol Scand 1982; 65: 110–121
   PubMedGoogle Scholar
• Johnsen B, Fuglsang-Frederiksen A, Vingtoft S, et al. Inter- and intra-observer variation in the interpretation of electromyographic tests. Electroencephalogr Clin Neurophysiol 1995; 97: 432–443
   PubMedGoogle Scholar
• Calore EE, Cavaliere MJ, Perez NM. Muscle pathology in juvenile dermatomyositis. Sao Paulo Med J 1997; 115: 1555–1559
   PubMedGoogle Scholar
• Dorph C, Nennesmo I, Lundberg IE. Percutaneous conchotome muscle biopsy. A useful diagnostic and assessment tool. J Rheumatol 2001; 28: 1591–1599
   PubMed Web of Science ®Google Scholar
• Li C, Varsani H, Maillard S, et al. Does histological features parallel clinical severity in juvenile dermatomyositis: Proposal of a novel scoring system. Clin Exp Rheumatol 2004; 22: 529
   Google Scholar
• Miller FW, Rider LG, Chung YL, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology 2001; 40: 1262–1273
   PubMed Web of Science ®Google Scholar
• Ravelli A, Duarte-Salazar C, Buratti S, et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: A multicenter cohort study. Arthritis Rheum 2003; 49: 501–507
   PubMedGoogle Scholar
• Ruperto N, Buratti S, Duarte-Salazar C, et al. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage. Arthritis Rheum 2004; 51: 458–464
   PubMed Web of Science ®Google Scholar
• Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–369
   PubMed Web of Science ®Google Scholar
• Ravelli A, Ruperto N, Martini A. Outcome in juvenile onset systemic lupus erythematosus. Curr Opin Rheumatol, (in press)
   Google Scholar
• Landgraf JM, Abetz L, Ware JEJ. The CHQ user's manual1st ed. The Health Institute, New England Medical Center, Boston, MA 1996
   Google Scholar
• Duffy CM, Arsenault L, Duffy KN, et al. The juvenile arthritis quality of life questionnaire-development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides. J Rheumatol 1997; 24: 738–746
   PubMed Web of Science ®Google Scholar
• Varni JW, Seid M, Smith Knight T, et al. The pedsQL in pediatric rheumatology: Reliability, validity and responsiveness of the pediatric quality of life inventory generic core scales and rheumatology module. Arthritis Rheum 2002; 46: 714–725
   PubMed Web of Science ®Google Scholar
• Ruperto N, Woo P, Cuttica R, et al. The validated PRINTO core set and definition of improvement for juvenile myositis. Arthritis Rheum 2004; 50(Suppl.)S534
   PubMedGoogle Scholar
• Ruperto N, Martini A. International research networks in pediatric rheumatology: The PRINTO perspective. Curr Opin Rheumatol 2004; 16: 566–570
   PubMed Web of Science ®Google Scholar
• Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003; 42(12)1452–1459
   PubMedGoogle Scholar
• Rider LG, Giannini EH, Brunner HI, et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004; 50: 2281–2290
   PubMed Web of Science ®Google Scholar